[1]
Talaviya, P.A., Vyas, B.M., Indoria, S.P. and Modh, V.B. 2017. Review on special emphasis of bortezomib on relapsed/refractory myeloma. International Journal of Research in Medical Sciences. 2, 4 (Jan. 2017), 1278–1282.